Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Beryl Drugs Ltd has filed a compliance certificate for the quarter ended March 31, 2026, confirming adherence to SEBI regulations regarding share transfers and certificate issuances. The certificate from Practicing Company Secretary Dipika Kataria verifies that share transfers were processed within the mandated 30-day timeframe. Notably, no share transfers were affected during the period, and no share certificates were issued for sub-division, consolidation, renewal, or exchange. The company uses Adroit Corporate Services Private Limited as its share transfer agent. This is a routine regulatory filing as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
No direct impact on shareholders or stock price. This is a standard compliance confirmation indicating the company followed proper regulatory procedures. The absence of share transfers during the period suggests low trading activity or no major shareholder movements.